EOR pharm exam part 1 Flashcards
MOA of statins
Inhibit HMG-CoA reductase
Effects on lipid profile of statins
Decrease LDL by 25-62%
Moderate reduction in TG
Minor increase in HDL
`Most common SEs of statins
Constipation Abdominal pain Diarrhea Dyspepsia Nausea
Other SEs of statins
Myopathy including rhabdomyolysis
Increased BG/HbA1c
Cognitive impairment
Pregnancy category X
Monitoring of statins
LFTs -Baseline for all pts -Fu only if clinically indicated Creatinine Kinase -Baseline in those at risk for myopathy -Fu if clinical signs or sx of myopathy -Assess for sx of myopathy 6-12 after drug initiation and at each visit thereafter
Dose ranges of atorvastatin
10-80 mg
Dose ranges of fluvastatin
20-80 mg
Special considerations of atorvastatin
Preferred in renal impairment
Special considerations of fluvastatin
Preferred in renal impairment
Dose ranges of lovastatin
20-80 mg
Special considerations of lovastatin
Increased absorption with food
Adjust starting doses if severe renal impairment
Dose ranges of pitavastatin
1-4 mg
Special considerations of pitavastatin
Decreased absorption with food
Adjust starting dose if severe renal impairment
Dose ranges of pravastatin
10-40 mg
Special considerations of pravastatin
Decreased absorption with food
Adjust starting doses if severe renal impairment
Hydrophilic
Dose ranges of rosuvastatin
10-40 mg
Special considerations of rosuvastatin
Adjust starting doses if severe renal impairment
Hydrophilic
Dose ranges of simvastatin
10-40 mg
Special considerations of simvastatin
Adjust starting doses if severe renal impairment
What statin should you consider switching your pts to if they experience myopathies?
Pravastatin and rosuvastatin
Gemfibrozil and statins
Contraindicated with statins but if use necessary, pravastatin is necessary